KEAP1 and neoplasm: These cells carry an activating mutation in the KRAS oncogene but still exhibit low ROS, because inactivation of the KEAP1 tumor suppressor gene in these cells leads to greater accumulation of NRF2 in the nucleus and increased activation of genes coding for antioxidants [36].